Control Bionics Share Price and Company Fundamentals
Last traded: Today at 2:11 AM
Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally. It offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. The company also provides the NeuroStrip, a wearable, miniaturized electromyography device; NeuroNode, a wireless, wearable sensor that allows users to access technology through bioelectric signals and spatial movements; and Cosmos Connect, a small portable control device that turns a single NeuroNode sensor into multiple outputs. In addition, it offers mounting systems under the Rehadapt brand, including wheelchair mounts, floor stands, and table stands; switch systems comprising proximity, press, and finger switches; and the autonomous wheelchair module under the DROVE brand. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is headquartered in Cremorne, Australia.
Key Metrics
PE ratio
-
PB ratio
3.16
Dividend yield
-
Beta
0.01
Market cap
$24.72M
Enterprise value
$17.44M
Company profile
| Industry / Sector | Medical Devices / Healthcare |
|---|---|
| Website | https://www.controlbionics.com |
| Mailing address | 11-13 Pearson Street Level 4 Cremorne VIC 3121 Australia |
| Phone / Fax | 61 3 9897 3576 / |
Dividends
More: Control Bionics Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Control Bionics paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CBL dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Control Bionics.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Jeremy E. Steele | CEO, MD & Executive Director | ||
| Ms. Shannon Boothroyd | Chief Financial Officer | ||
| Mr. Todd Tyler | US Country Manager | ||
| Mr. James Schorey | Chief Technology Officer | ||
| Mr. Brett Thomas Crowley B.Com., C.A., DipLaw | Company Secretary | 68 |
Profitability and management effectiveness
Profit margin
-99.41%
Operating margin
-86.93%
Return on assets
-43.14%
Return on equity
-103.74%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Control Bionics is 24.72M and its enterprise value is 17.44M. The enterprise value to revenue ratio of CBL is 2.84. The enterprise value to EBITDA ratio of CBL is -3.39.
The CBL's stocks Beta value is 0.01 making it 99% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Control Bionics (CBL)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Control Bionics (ASX:CBL) Frequently Asked Questions
1. What is Control Bionics's Stock Symbol?
Control Bionics trades on ASX under the ticker symbol "CBL".
2. What is Control Bionics's stock price today?
One share of CBL stock can currently be purchased for approximately $0.06.
3. How can I contact Control Bionics?
Control Bionics's mailing address is 11-13 Pearson Street Level 4 Cremorne VIC 3121 Australia. The company can be reached via phone at 61 3 9897 3576.
4. What is Control Bionics's official website?
The official website of Control Bionics is https://www.controlbionics.com.